Beezle Extracts

Beezle Extracts concentrated nearly four-fifths of July 2026 revenue in two pillars: Vapor Pens at 42.44% share and Concentrates at 36.65% share, but the momentum split is stark — Vapor Pens fell 8.94% year over year even as month-over-month rose 15.90%, while Concentrates climbed 14.55% year over year on a modest 1.43% month-over-month uptick. Edible contracted, with share at 13.76% and a 19.78% year-over-year decline despite a 0.82% month-over-month lift, and Pre-Roll held 6.37% share with 3.25% year-over-year growth but a 1.75% month-over-month dip; Flower remained tiny at 0.78% share yet surged 97.65% month over month from a small base. With an average price up 7.41% year over year to $27.08 alongside Vapor Pens’ price point at 26.37 and Concentrates at 34.20, the mix indicates a pivot toward higher-margin extracts cushioning a -1.88% overall sales decline, implying that near-term growth depends on protecting Concentrates’ yearly gains while selectively rebuilding Vapor Pens’ trajectory.

In positioning terms, the category tilt signals that Beezle Extracts is increasingly anchored in extract-centric baskets where Concentrates’ 14.55% year-over-year growth can offset Vapor Pens’ 8.94% annual contraction, and the 15.90% month-over-month rebound in Vapor Pens provides a near-term lever to stabilize share at the top of the funnel. Holding rank 14 in Vapor Pens in Maryland while Concentrates comp growth outpaces Edible’s 19.78% annual decline suggests prioritizing extract formats and cross-format upsell from Vapor Pens into Concentrates, because a 1.43% month-over-month gain in Concentrates combined with a 0.82% lift in Edible indicates incremental volume is available but best captured where price tolerance is higher.